Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isolation of Cultures of Epithelial Tumor Cells and Cancer-associated Fibroblasts (CAF) From Primary Squamous Cell Carcinoma of the Head and Neck and Study of HLA-DR Expression

NCT06041464 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT06041464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06041464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isolation of Cultures of Epithelial Tumor Cells and Cancer-associated Fibroblasts (CAF) From Primary Squamous Cell Carcinoma of the Head and Neck and Study of HLA-DR Expression
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Unknown status
Start date
March 2, 2021
Completion date
March 2, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, squamous cell carcinoma of the head and neck